BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 36992399)

  • 1. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
    Mazurov D; Ramadan L; Kruglova N
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
    Li X; Shi W; Geng LZ; Xu JP
    Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
    Wilbie D; Walther J; Mastrobattista E
    Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
    Bloomer H; Khirallah J; Li Y; Xu Q
    Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of CRISPR-Cas12a Ribonucleoprotein Complex for Genome Editing in an Embryogenic Citrus Cell Line.
    Fang H; Culver JN; Niedz RP; Qi Y
    Methods Mol Biol; 2023; 2653():153-171. PubMed ID: 36995625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing.
    Onuma H; Sato Y; Harashima H
    J Control Release; 2023 Mar; 355():406-416. PubMed ID: 36773957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition.
    Suzuki Y; Onuma H; Sato R; Sato Y; Hashiba A; Maeki M; Tokeshi M; Kayesh MEH; Kohara M; Tsukiyama-Kohara K; Harashima H
    J Control Release; 2021 Feb; 330():61-71. PubMed ID: 33333121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing via delivery of Cas9 ribonucleoprotein.
    DeWitt MA; Corn JE; Carroll D
    Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
    Bykonya AG; Lavrov AV; Smirnikhina SA
    Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
    Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
    Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells.
    Tyumentseva MA; Tyumentsev AI; Akimkin VG
    PLoS One; 2021; 16(11):e0259812. PubMed ID: 34752487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
    Naeem M; Majeed S; Hoque MZ; Ahmad I
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
    Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).
    Perera OP; Little NS; Pierce CA
    PLoS One; 2018; 13(5):e0197567. PubMed ID: 29771955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms.
    Farboud B; Jarvis E; Roth TL; Shin J; Corn JE; Marson A; Meyer BJ; Patel NH; Hochstrasser ML
    J Vis Exp; 2018 May; (135):. PubMed ID: 29889198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
    Kim H; Choi J; Won KH
    BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.
    Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B
    J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.